)
Marina Udier, PhD
CEO
Nouscom
Marina Udier, PhD, is the Chief Executive Officer of Nouscom, a clinical stage oncology company headquartered in Basel, Switzerland. Since assuming leadership six years ago, she has guided the company through its first IND clearance and multiple successful regulatory interactions across the US and Europe, establishing Nouscom as a pioneer in cancer interception.
Under her leadership, Nouscom completed an oversubscribed Series C financing round in 2023–24, raising $97M to advance and expand its clinical programs. Prior to joining Nouscom, Marina served as an Operating Principal at Versant Ventures, where she helped build and operationalize early stage biotech companies. Earlier in her career, she spent seven years at Novartis Pharma in both development and commercial roles, contributing to the approval of the companion diagnostic for Rydapt™.
Marina began her professional journey at McKinsey & Company’s healthcare practice in Chicago, advising Fortune 500 clients on strategy and pricing. She holds a PhD in Chemistry from Yale University.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}